Analysis method for chemical components of meridian-clearing powder

Through the analysis method of ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry, the problem of insufficient detection sensitivity and resolution of Qingjingsan components was solved, and a rapid, comprehensive and efficient chemical composition analysis was achieved. A total of 277 were identified. a compound.

CN119086738APending Publication Date: 2024-12-06SHANGHAI INST OF PHARMA IND CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410879669.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-02
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

In the prior art, the detection methods of Qingjingsan chemical components are not sensitive enough, and components with similar polarity are difficult to separate, and the analysis time is long, making it difficult to fully characterize their chemical components.

Method used

UPLC-Q-TOF-MS combined analysis method is used to detect specific chromatography and mass spectrometry conditions, including the use of octadecyl-bonded silica gel columns and gradients. Elution and electrospray ionization sources enable fast and efficient chemical composition analysis.

Benefits of technology

Achieve rapid, high sensitivity and good separation analysis of Qingjing Powder chemical components, a total of 277 compounds were identified, overcoming the problem of difficult separation and long analysis of components with similar polarity, and providing Qingjing Powder and its preparations The basis for the analysis of all components.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119086738A_ABST
    Figure CN119086738A_ABST
Patent Text Reader

Abstract

The invention discloses a method for analyzing chemical components of a meridian-clearing powder. The method for analyzing the chemical components of the Qingshui powder comprises the following steps: detecting a Qingshui powder solution by using an ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry analysis method. The analysis method provided by the invention can efficiently, quickly, accurately and more comprehensively analyze and characterize the chemical components of the Qingshui powder, and overcomes the problems that the chemical components in a Qingshui powder system are difficult to separate and characterize and the analysis time of an instrument is short, so that a basis can be provided for analysis and characterization of the chemical components of the Qingshui powder and preparations thereof.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an analysis method for the chemical components of Qingjing powder. Background Art

[0002] Qingjingsan comes from Fu Shan's book Fu Qingzhu Nvke. It is a classic gynecological prescription commonly used in clinical practice. It is mainly used to treat premature menstruation. The whole prescription is composed of seven herbs: peony bark, ground bone bark, white peony root, cooked rehmannia root, artemisia annua, Poria cocos, and salt phellodendron. It is decocted in water. Qingjingsan is the 88th prescription in the "Ancient Classic Prescriptions (First Batch)" issued by the State Administration of Traditional Chinese Medicine in 2018. It is the first choice for treating premature menstruation. It has a long history, a clear prescription source, and no toxic taste. It has important research and development value. Fingerprint spectrum combined with multi-component qualitative analysis is a commonly used analytical method for quality research of traditional Chinese medicine, which can more comprehensively characterize the overall chemical composition of traditional Chinese medicine preparations. At present, most reports on Qingjingsan are clinical studies, and there are very few studies on its chemical composition analysis.

[0003] At present, there is only one research paper on the chemical composition analysis of Qingjing Powder: Zhao Zazan, Liu Yujun, Zhao Liyan, et al. Study on the value transfer of key quality attributes of material benchmark of the classic prescription Qingjing Powder [J]. Chinese Modern Chinese Medicine, 2023, 25(06): 1302-1310. DOI: 10.13313 / j.issn.1673-4890.20221212001. The article only identified 6 components in Qingjing Powder, including: peony lactone glycosides (from white peony root, peony bark), paeoniflorin (from white peony root, peony bark), scopoletin (from Lycium bark, Artemisia annua), verbascoside (from Rehmannia glutinosa), paeonol (from peony bark) and berberine (from Phellodendron chinense). Moreover, the detection method in this document is high performance liquid chromatography, which has a long analysis and detection time of about 75 minutes. In addition, the high performance liquid chromatography-ultraviolet spectroscopy detection method has insufficient analytical sensitivity for a complex system such as Qingjing Powder. Some chemical components are difficult to separate, have low or no response, and are even more difficult to characterize.

[0004] Therefore, there is an urgent need to provide an efficient, rapid, accurate and more comprehensive Qingjing Powder component analysis method to provide a basis for the full component analysis of Qingjing Powder and its preparations. Summary of the invention

[0005] The technical problem to be solved by the present invention is that the detection method of the chemical components in Qingjing Powder in the prior art has the defects of insufficient analytical sensitivity, difficulty in separating and characterizing chemical components with similar polarity, and long analytical method time, and provides an analytical method for the chemical components of Qingjing Powder. The analytical method of the present invention can efficiently, quickly, accurately, and more comprehensively analyze and characterize the chemical components of Qingjing Powder, overcomes the problems of difficulty in separating and characterizing the chemical components in the Qingjing Powder system, and short instrumental analysis time, thereby providing a basis for the analysis and characterization of the chemical components of Qingjing Powder and its preparations.

[0006] The present invention solves the above technical problems through the following technical solutions.

[0007] The present invention provides a method for analyzing the chemical components of Qingjing Powder, the steps of which include:

[0008] The Qingjingsan solution was analyzed by ultra-performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry (UPLC-Q-TOF-MS);

[0009] Wherein, the detection conditions of the ultra-high performance liquid chromatography are:

[0010] The stationary phase of the chromatographic column is octadecyl bonded silica gel;

[0011] The mobile phase includes aqueous phase A and organic phase B;

[0012] The aqueous phase A is a mixture of formic acid and water, wherein the formic acid accounts for 0.1% of the total volume of the aqueous phase A;

[0013] The organic phase B is acetonitrile;

[0014] The flow rate of the mobile phase is 0.3 mL / min;

[0015] The detection condition of the ultra-high performance liquid chromatography is gradient elution, with the total volume of the mobile phase being 100%; within 33 minutes, the volume of the organic phase B increases from 3% to 90%.

[0016] In the present invention, preferably, the detection conditions of the quadrupole tandem time-of-flight mass spectrometry meet one or more of the following conditions:

[0017] a. The ion source is an electrospray ionization source (ESI);

[0018] b. The temperature of the ion source is 100°C;

[0019] c. The ionization modes are respectively selected as positive ionization mode and negative ionization mode; wherein, in the positive ionization mode, the capillary voltage is 3 kV; and in the negative ionization mode, the capillary voltage is 2 kV;

[0020] d. Collision energy is 30-60eV;

[0021] e. The scanning mode is full scan;

[0022] f. The scanning range is the mass-to-charge ratio (m / z) range of 50-1500Da;

[0023] g. Scan time is 0.3s;

[0024] h. The atomizing gas is nitrogen;

[0025] i. The cone gas is nitrogen;

[0026] j. The cone sampling voltage is 40V;

[0027] k. The cone hole gas flow rate is 50L / h;

[0028] 1. The desolvation temperature is 250°C;

[0029] m. The desolvation gas flow rate is 600L / h.

[0030] In the present invention, the ultra-high performance liquid chromatography is generally connected in series with the quadrupole tandem time-of-flight mass spectrometer.

[0031] In the present invention, the Qingjingsan solution can be a Qingjingsan full-formula medicinal material solution, a Qingjingsan single-formula medicinal material solution, or a Qingjingsan missing-formula medicinal material solution.

[0032] In the present invention, preferably, the crude drug concentration of the Qingjingsan solution is 3.6-65.3 mg / mL. The "crude drug concentration" refers to the mass (mg) of the medicinal material used in preparing the solution / the volume (mL) of the solution.

[0033] In the present invention, the Qingjing Powder solution is prepared by the following method, which includes: water decoction and solid phase extraction, preferably, including water decoction, volume determination and solid phase extraction.

[0034] The water decoction operation can adopt the conventional water decoction operation method in the art, and the purpose of the water decoction is generally to prepare the Qingjing Powder decoction.

[0035] The volume fixing operation may adopt a conventional volume fixing operation method in the art.

[0036] The solid phase extraction operation can be carried out by conventional solid phase extraction operation methods in the art.

[0037] In a specific embodiment of the present invention, the water decoction operation includes: adding 600 mL of water to Qingjing Powder, soaking for 2 hours, heating the first decoction to boiling at 500W over high heat, keeping the medicinal liquid slightly boiling at 200W over low heat, filtering the first decoction while hot through nylon cloth (300 mesh) after 30 minutes, adding 480 mL of water to the second decoction, heating the second decoction to boiling at 500W over high heat, keeping the medicinal liquid slightly boiling at 200W over low heat, filtering the second decoction while hot through nylon cloth (300 mesh) after 20 minutes, combining the two decoctions, cooling, and measuring the volume to obtain the Qingjing Powder water decoction.

[0038] In a specific embodiment of the present invention, the volume adjustment operation includes: pouring the cooled Qingjingsan decoction into a 1000mL volumetric flask, adjusting the volume to the scale line with water, and shaking well.

[0039] In a specific embodiment of the present invention, the solid phase extraction operation includes: accurately measuring 25 mL of Qingjingsan water decoction fixed to 1000 mL in a 50 mL centrifuge tube, centrifuging at a centrifugal speed of 4000 r / min for 4 minutes, taking the supernatant, saturating a 1g / 6ml 30 / pkg solid phase extraction column with 5 mL of methanol, and then slowly adding 20 mL of the water decoction supernatant after centrifugation to the solid phase extraction column. After the loading is completed, 5 mL of pure water is added to remove impurities, eluted with 10 mL of methanol, and the eluate is transferred to a rotary evaporator and spin-dried. The rotary evaporator water bath temperature is 47°C, and 7.5 mL of methanol is accurately transferred to re-dissolve, and filtered through a 0.45 μm nylon membrane to obtain a Qingjingsan solution.

[0040] In the present invention, preferably, the chromatographic column of the ultra-high performance liquid chromatography is of Waters ACUITY CSH TM C18 column.

[0041] In the present invention, preferably, the inner diameter of the chromatographic column of the ultra-high performance liquid chromatography is 2.1 mm and the length is 100 mm.

[0042] In the present invention, preferably, in the chromatographic column of the ultra-high performance liquid chromatography, the particle size of the filler is 1.7 μm.

[0043] In the present invention, preferably, the injection volume of the ultra-high performance liquid chromatography is 2 μL.

[0044] In the present invention, preferably, the injection volume of the ultra-high performance liquid chromatography satisfies the requirement that the chromatographic peak response value of the ultra-high performance liquid chromatography is e 6 .

[0045] In the present invention, preferably, the column temperature of the ultra-high performance liquid chromatography is 40°C.

[0046] In the present invention, preferably, the temperature of the sample plate of the ultra-high performance liquid chromatography is 8-12°C, for example, 10°C.

[0047] In some preferred embodiments of the present invention, based on the total volume of the mobile phase as 100%, the gradient elution of the ultra-high performance liquid chromatography comprises one or more of the following processes:

[0048] a. Within 0.5 min, the volume of the organic phase B increased from 3% to 7%;

[0049] b. Within 3.5 min, the volume of the organic phase B increased from 7% to 13%;

[0050] c. Within 3 minutes, the volume of the organic phase B increased from 13% to 15%;

[0051] d. Within 2 minutes, the volume of the organic phase B increased from 15% to 18%;

[0052] e. Within 3 minutes, the volume of the organic phase B increased from 18% to 25%;

[0053] f. Within 6 minutes, the volume of the organic phase B increased from 25% to 42%;

[0054] g. Within 4 minutes, the volume of the organic phase B increased from 42% to 50%;

[0055] h. Within 2 minutes, the volume of the organic phase B increased from 50% to 59%;

[0056] i. Within 3 min, the volume of the organic phase B increased from 59% to 67%;

[0057] j. Within 2 minutes, the volume of the organic phase B increased from 67% to 76%;

[0058] k. Within 1 min, the volume of the organic phase B increased from 76% to 81%;

[0059] 1. Within 3 minutes, the volume of the organic phase B increased from 81% to 90%.

[0060] In a specific embodiment of the present invention, the gradient elution of the ultra-high performance liquid chromatography comprises the following process: based on the total volume of the mobile phase as 100%,

[0061] At 0-2 min, the volume of the organic phase B was 3%;

[0062] At 2-2.5 min, the volume of the organic phase B was increased from 3% to 7%;

[0063] At 2.5-6 min, the volume of the organic phase B increased from 7% to 13%;

[0064] At 6-9 min, the volume of the organic phase B was increased from 13% to 15%;

[0065] At 9-11 min, the volume of the organic phase B increased from 15% to 18%;

[0066] At 11-14 min, the volume of the organic phase B increased from 18% to 25%;

[0067] At 14-20 min, the volume of the organic phase B increased from 25% to 42%;

[0068] At 20-24 min, the volume of the organic phase B increased from 42% to 50%;

[0069] At 24-26 min, the volume of the organic phase B increased from 50% to 59%;

[0070] At 26-29 min, the volume of the organic phase B increased from 59% to 67%;

[0071] At 29-31 min, the volume of the organic phase B increased from 67% to 76%;

[0072] At 31-32 min, the volume of the organic phase B increased from 76% to 81%;

[0073] At 32-35 min, the volume of the organic phase B increased from 81% to 90%;

[0074] At 35-35.1 min, the volume of the organic phase B decreased from 90% to 3%;

[0075] At 35.1-37 min, the volume of the organic phase B was 3%.

[0076] In the present invention, preferably, the instrument model of the quadrupole tandem time-of-flight mass spectrometer is Waters XevoG2, produced by Waters Corporation of the United States.

[0077] In the present invention, the quadrupole tandem time-of-flight mass spectrometer generally needs to be calibrated with an internal reference before use.

[0078] Preferably, the internal reference calibration is performed using a leucine enkephalin solution, whose theoretical molecular weight is 556.2771 in positive ion mode (ESI+), and whose theoretical molecular weight is 554.2615 in negative ion mode (ESI-). More preferably, the concentration of the leucine enkephalin solution is 1 μg / L.

[0079] Preferably, the calibrated flow rate is 5 μL / min.

[0080] Preferably, the correction frequency is 5s.

[0081] In the present invention, preferably, the spectrum obtained by detecting the Qingjing Powder solution by the ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry analysis method is imported into UNIFI 1.8 analysis software to screen and identify the full-component compounds of Qingjing Powder, and confirmed in combination with the spectrum of some standard products.

[0082] Preferably, the spectrum of the standard is obtained by detecting the standard solution through the ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry (UPLC-Q-TOF-MS) combined analysis method.

[0083] Wherein, when the molecular weights of the standards are different, a mixed standard solution can be injected; when the molecular weights of the standards are the same, the standards are injected individually.

[0084] Preferably, the concentration of the standard solution is 0.1-3 mg / mL.

[0085] Preferably, the UNIFI 1.8 analysis software includes a chemical composition information library, which is established by collecting literature summaries. The UNIFI 1.8 analysis software is a Waters workstation.

[0086] Preferably, when the UNIFI 1.8 analysis software is used for identification, compounds with an error within ±5 ppm and a response value > 10,000 are selected.

[0087] On the basis of being in accordance with the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.

[0088] The reagents and raw materials used in the present invention are commercially available.

[0089] The positive and progressive effects of the present invention are:

[0090] The analytical method for the chemical components of Qingjing Powder provided by the present invention has a short instrument analysis time, and can be quickly detected in only 37 minutes; it has high sensitivity and good separation, and overcomes the problem that the chemical components in the Qingjing Powder system are difficult to separate and identify, and can perform a more comprehensive analysis and identification of the chemical components in Qingjing Powder. A total of 277 compounds were identified, including 7 sugars, 100 terpenes, 39 phenylpropanoids, 31 flavonoids, 32 alkaloids, 21 organic acids, and 47 other types.

[0091] Among them, 116 chemical components were characterized in Paeonia suffruticosa, 102 chemical components were characterized in Paeonia lactiflora, 70 chemical components were characterized in Lycium bark, 66 chemical components were characterized in Rehmannia glutinosa, 45 chemical components were characterized in Phellodendron chinense, 62 chemical components were characterized in Artemisia annua, and 14 chemical components were characterized in Poria. The compound information is shown in Table 2.

[0092] Therefore, the analysis method of the present invention can efficiently, quickly, accurately and more comprehensively analyze and characterize the chemical components of Qingjing Powder, thereby providing a basis for the full component analysis of Qingjing Powder and its preparations. BRIEF DESCRIPTION OF THE DRAWINGS

[0093] Figure 1 This is the UPLC-Q-TOF-MS base peak chromatogram under positive electrode mode of the Qingjing Powder whole prescription medicinal material solution in Example 1.

[0094] Figure 2 This is the UPLC-Q-TOF-MS base peak chromatogram under negative electrode mode of the Qingjing Powder whole prescription medicinal material solution in Example 1.

[0095] Figure 3 This is the UPLC-Q-TOF-MS base peak chromatogram of the standard substance benzoyloxypaeoniflorin in Example 1 under negative electrode mode.

[0096] Figure 4 This is the base peak chromatogram of UPLC-Q-TOF-MS in positive electrode mode of the standard substance benzoyloxypaeoniflorin in Example 1.

[0097] Figure 5 This is the total ion current diagram of UPLC-Q-TOF-MS in the negative electrode mode of the standard substance Paeonia suffruticosa C in Example 1.

[0098] Figure 6 This is the total ion current diagram of UPLC-Q-TOF-MS in positive electrode mode for the standard substance Paeonia suffruticosa C in Example 1.

[0099] Figure 7 This is the total ion current diagram of UPLC-Q-TOF-MS in negative electrode mode of the mixed standard in Example 1.

[0100] Figure 8 This is the total ion current diagram of UPLC-Q-TOF-MS in positive electrode mode of the mixed standard in Example 1.

[0101] Fig. 9 This is the total ion current diagram of UPLC-Q-TOF-MS in the negative electrode mode of the standard paeoniflorin in Example 1.

[0102] Fig.10 This is the total ion current diagram of UPLC-Q-TOF-MS in positive electrode mode for the standard substance paeoniflorin in Example 1.

[0103] Fig.11 This is the total ion current diagram of UPLC-Q-TOF-MS in the negative electrode mode of the standard substance paeoniflorin in Example 1.

[0104] Fig.12 This is the total ion current diagram of UPLC-Q-TOF-MS in positive electrode mode for the standard substance paeoniflorin in Example 1.

[0105] Fig.13 This is the total ion current diagram of UPLC-Q-TOF-MS in positive electrode mode for the standard substance 3-O-feruloylquinic acid in Example 1.

[0106] Fig.14 This is the total ion current diagram of UPLC-Q-TOF-MS in the negative electrode mode of the standard substance 3-O-feruloylquinic acid in Example 1.

[0107] Fig.15 This is the total ion current diagram of UPLC-Q-TOF-MS in positive electrode mode for the standard substance 5-O-feruloylquinic acid in Example 1.

[0108] Fig.16 This is the total ion current diagram of UPLC-Q-TOF-MS in the negative electrode mode of the standard substance 5-O-feruloylquinic acid in Example 1.

[0109] Fig.17 This is the UPLC-Q-TOF-MS base peak chromatogram under positive electrode mode of the Qingjing Powder whole prescription medicinal material solution in Comparative Example 1. DETAILED DESCRIPTION

[0110] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.

[0111] (1) Experimental medicinal materials and standard products:

[0112] Ingredients for Qingjing Powder:

[0113] Peony bark (batch number MDP002), white peony root (batch number 20230527), Chinese wolfberry bark (batch number DGP002), Rehmannia root (batch number SDH002), Artemisia annua (batch number QH002), Poria (batch number BFL001), salted phellodendron (batch number YZ-3)

[0114] Standards:

[0115] Benzoylpaeoniflorin (Batch No. 13193, Shanghai Standard Standard Technology Service Co., Ltd.),

[0116] N-trans-feruloyltyramide (Batch No. 6340, Shanghai Standard Standard Technology Service Co., Ltd.), artemisinin (Batch No. 9183, Shanghai Standard Standard Technology Service Co., Ltd.)

[0117] Paeonol (Batch No. 110708-201908, China Food and Drug Inspection Institute),

[0118] Galloylpaeoniflorin (Batch No. 13999, Shanghai Standard Standard Technology Service Co., Ltd.),

[0119] Oxidized paeoniflorin (Batch No. 12793, Shanghai Standard Standard Technology Service Co., Ltd.),

[0120] Paeoniflorin sulfite (Batch No. 15002, Shanghai Standard Standard Technology Service Co., Ltd.),

[0121] Gallic acid (Batch No. 12545, Shanghai Shidande Standard Technology Service Co., Ltd.);

[0122] Catechins (Batch No. 7905, Shanghai Shidande Standard Technology Service Co., Ltd.), Rehmannia glutinosa (Batch No. 112063-202103, China Food and Drug Administration)

[0123] Paeoniflorin (Batch No. 9606, Shanghai Standard Standard Technology Service Co., Ltd.), Paeoniflorin (Batch No. 110736-202246, China Food and Drug Administration)

[0124] Paeonia suffruticosa C (Batch No. 14876, Shanghai Standard Standard Technology Service Co., Ltd.),

[0125] Benzoyloxypaeoniflorin (Batch No. 10072, Shanghai Shidande Standard Technology Service Co., Ltd.), 3-O-feruloylquinic acid (Batch No. 14759, Shanghai Shidande Standard Technology Service Co., Ltd.), 5-O-feruloylquinic acid (Batch No. 10220, Shanghai Shidande Standard Technology Service Co., Ltd.).

[0126] (2) Experimental reagents:

[0127] Acetonitrile (LC-MS grade), methanol (analytical grade), water (Watsons distilled water), formic acid (LC-MS grade)

[0128] (3) Experimental instruments:

[0129] Quadrupole tandem time-of-flight mass spectrometry (Q-TOF-MS) (Waters XevoG2, Waters Company, USA);

[0130] Column: Waters ACUITY CSH TMC18 1.7 μm column (2.1 × 100 mm);

[0131] MS204TS analytical balance (Shanghai Mettler Toledo Instrument Co., Ltd.);

[0132] Rotary evaporator (Heidoph Hei-VAP Value, Germany);

[0133] Solid phase extraction column (Cleanert S C18-N SPE, model: 1g / 6ml 30 / pkg);

[0134] Circulating water vacuum pump (Zhengzhou Great Wall Science and Technology Industry and Trade Co., Ltd.);

[0135] Solid phase extractor (Agela), 5ml pipette, rubber-tipped dropper, 15ml centrifuge tube.

[0136] Example 1

[0137] 1. Preparation of Qingjingsan whole prescription medicinal material solution:

[0138] Accurately weigh the medicinal materials of Qingjing Powder: Paeonia suffruticosa Andr. 11.19g, Lycium chinense Mill. 18.65g, Paeonia lactiflora Pall. 11.19g, Rehmannia glutinosa Libosch. 11.19g, Artemisia annua L. 7.46g, Poria cocos (Schw.) Wolf 3.73g, Phellodendron chinense Schneid. 1.87g. Add 600 mL of water to the medicinal materials of Qingjing San, soak for 2 hours, cover, heat the first decoction with high heat 500 W until boiling, start timing and adjust the low heat to 200 W to keep the medicine liquid slightly boiling, filter the first decoction through nylon cloth (300 mesh) while hot after 30 minutes, add 480 mL of water to the second decoction, heat with high heat 500 W until boiling, start timing and adjust the low heat to 200 W to keep it slightly boiling, filter the second decoction through nylon cloth (300 mesh) while hot after 20 minutes, combine the two decoctions, cool, measure the volume, and obtain the Qingjing San water decoction.

[0139] Pour the Qingjingsan decoction into a 1000mL volumetric flask, dilute to the mark with water, and shake well.

[0140] Accurately measure 25 mL of Qingjingsan decoction (fixed to 1000 mL) into a 50 mL centrifuge tube, centrifuge at 4000 r / min for 4 minutes, take the supernatant, saturate the 1g / 6ml 30 / pkg solid phase extraction column with 5 mL of methanol, and slowly add 20 mL of the supernatant of the decoction after centrifugation to the solid phase extraction column. After loading, add 5 mL of pure water to remove impurities, elute with 10 mL of methanol, transfer the eluate to a rotary evaporator and spin dry, set the rotary evaporator water bath temperature at 47 °C, accurately transfer 7.5 mL of methanol to re-dissolve, filter through a 0.45 μm nylon membrane, and obtain the Qingjingsan whole-prescription medicinal material solution with a crude drug concentration of 65.28 mg / mL.

[0141] 2. Preparation of Qingjingsan single medicinal material solution:

[0142] The preparation method of Qingjingsan single-ingredient medicinal material solution is basically the same as that of Qingjingsan full-ingredient medicinal material solution, the only difference is that in the preparation process of Qingjingsan single-ingredient medicinal material solution, the single-ingredient medicinal material of Qingjingsan is weighed, namely:

[0143] Weigh 11.19 g of Paeonia suffruticosa root to prepare a test solution of Paeonia suffruticosa root with a crude drug concentration of 11.19 mg / ml.

[0144] Weigh 18.65 g of Radix Lycii to prepare a Radix Lycii test solution with a crude drug concentration of 18.65 mg / mL.

[0145] Weigh 11.19 g of white peony root wine to prepare the white peony root wine test solution, and the crude drug concentration is 11.19 mg / mL.

[0146] Weigh 11.19 g of Rehmannia glutinosa to prepare a Rehmannia glutinosa test solution with a crude drug concentration of 11.19 mg / mL.

[0147] Weigh 7.46 g of Artemisia annua to prepare the Artemisia annua test solution, with the crude drug concentration being 7.46 mg / mL.

[0148] Weigh 3.73 g of Poria cocos to prepare a Poria cocos test solution with a crude drug concentration of 3.73 mg / mL.

[0149] Weigh 1.87 g of Phellodendron salsa to prepare a test solution of Phellodendron salsa, with a crude drug concentration of 1.87 mg / mL.

[0150] 3. Preparation of mixed standard solution

[0151] Take standard solutions of compounds with different molecular weights dissolved in pure methanol:

[0152] Benzoylpaeoniflorin 1.04 mg / mL;

[0153] N-trans-feruloyltyramide 0.25 mg / mL;

[0154] Artemisinin B 0.2 mg / mL;

[0155] Paeonol 1.63 mg / mL;

[0156] Galloylpaeoniflorin 0.25 mg / mL;

[0157] Oxidized paeoniflorin 0.56 mg / mL;

[0158] Peony sulfite 0.73 mg / mL;

[0159] Gallic acid 0.56 mg / mL;

[0160] Catechin 0.47 mg / mL;

[0161] 10 μL of each of 2.16 mg / mL of Rehmannia glutinosin D were uniformly mixed to prepare a mixed standard, and filtered through a 0.45 μm nylon membrane to obtain a mixed standard solution.

[0162] 4. Prepare a single standard solution

[0163] Standards with the same molecular weight were dissolved in pure methanol to obtain the following standard solutions, with concentrations of:

[0164] Peony lactone glycosides 1.06mg / ml;

[0165] Paeoniflorin 0.96mg / ml;

[0166] Paeonia suffruticosa C 0.81mg / ml;

[0167] Benzoyloxypaeoniflorin 0.62mg / ml;

[0168] 3-O-feruloylquinic acid 0.21 mg / ml;

[0169] 5-O-Feruloylquinic acid 0.53 mg / ml.

[0170] 5. UPLC-Q-TOF-MS was used to detect the Qingjingsan whole-prescription medicinal material solution, Qingjingsan single-prescription medicinal material solution, mixed standard solution and each single standard solution.

[0171] Sample injection, ultra-high performance liquid chromatography tandem quadrupole tandem time-of-flight mass spectrometry detection:

[0172] Wherein, the detection conditions of the ultra-high performance liquid chromatography are:

[0173] Injection volume: 2 μL

[0174] Sample plate temperature: 10°C

[0175] Chromatographic column: Waters ACUITY CSHTM C18 1.7μm column (2.1×100mm)

[0176] Column temperature: 40°C

[0177] Aqueous phase A: a mixture of 0.1% formic acid and water

[0178] Organic phase B: acetonitrile

[0179] Gradient elution was used, and the elution gradient is shown in Table 1:

[0180] Table 1

[0181]

[0182]

[0183] Among them, the mass spectrometry detection conditions are:

[0184] Instrument model: Waters XevoG2, Waters, USA

[0185] Ion source: ESI

[0186] Ion source temperature: 100°C

[0187] Ionization mode: positive ion mode and negative ion mode

[0188] In positive ionization mode, the capillary voltage is 3 kV; in negative ionization mode, the capillary voltage is 2 kV

[0189] Collision energy: 30-60eV

[0190] Scan mode: Full scan

[0191] Scanning range: mass-to-charge ratio (m / z) in the range of 50-1500Da

[0192] Scan time: 0.3s;

[0193] Atomizing gas: Nitrogen

[0194] Cone gas: Nitrogen

[0195] Cone sampling voltage: 40V

[0196] Cone hole gas flow: 50L / h

[0197] Desolventization temperature: 250°C;

[0198] Desolvation gas flow rate: 600L / h

[0199] Among them, mass spectrometry internal reference calibration:

[0200] The internal reference was calibrated with a leucine enkephalin solution, whose theoretical molecular weight was 556.2771 in positive ion mode (ESI+), and 554.2615 in negative ion mode (ESI-). The concentration of the leucine enkephalin solution was 1 μg / L, the flow rate was 5 μL / min, and the calibration frequency was 5 s.

[0201] Among them, the results are as follows:

[0202] The base peak chromatogram of the UPLC-Q-TOF-MS in the positive electrode mode of the Qingjingsan whole prescription medicinal material solution is shown in Figure 1 The base peak chromatogram of the UPLC-Q-TOF-MS in the negative electrode mode of the Qingjingsan whole prescription medicinal material solution is shown in Figure 2 .

[0203] The base peak chromatogram of the standard benzoyloxypaeoniflorin in negative electrode mode of UPLC-Q-TOF-MS is shown in Figure 3 UPLC-Q-TOF-MS base peak chromatogram of standard benzoyloxypaeoniflorin in positive mode is shown in Figure 4 .

[0204] The total ion current of UPLC-Q-TOF-MS in negative electrode mode for standard peony glycoside C is shown in Figure 5 UPLC-Q-TOF-MS total ion current diagram of standard peony glycoside C in positive mode is shown in Figure 6 .

[0205] The total ion current of UPLC-Q-TOF-MS in negative electrode mode of mixed standard is shown in Figure 7 UPLC-Q-TOF-MS total ion current diagram of mixed standard in positive mode is shown in Figure 8 .

[0206] The total ion current of UPLC-Q-TOF-MS in negative electrode mode of standard paeoniflorin is shown in Fig. 9 UPLC-Q-TOF-MS total ion current diagram of standard paeoniflorin in positive mode is shown in Fig.10 .

[0207] The total ion current of UPLC-Q-TOF-MS in negative electrode mode for standard paeoniflorin is shown in Fig.11 UPLC-Q-TOF-MS total ion current diagram of standard paeoniflorin in positive mode is shown in Fig.12 .

[0208] The total ion current of UPLC-Q-TOF-MS in positive mode of standard 3-O-feruloylquinic acid is shown in Fig.13 UPLC-Q-TOF-MS total ion current of standard 3-O-feruloylquinic acid in negative electrode mode is shown in Fig.14 .

[0209] The total ion current of UPLC-Q-TOF-MS in positive mode of standard 5-O-feruloylquinic acid is shown in Fig.15 UPLC-Q-TOF-MS total ion current diagram of standard 5-O-feruloylquinic acid in negative electrode mode is shown in Fig.16 .

[0210] Among them, the total ion flow diagram and the base peak chromatogram are two different representations of the mass spectrometry data obtained from the same acquisition. The base peak chromatogram can smooth the noise and make the peak shape more prominent.

[0211] 6. Compare and analyze the spectrum of the standard product and the chemical component information database of the Qingjingsan formula

[0212] The method of creating the Qingjingsan Quanfang information database:

[0213] The chemical composition information of relevant medicinal flavors was collected through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), and combined with the research literature and research progress literature of each medicinal flavor. Some references: Zhiqiang W, Chunnian H, Yong P, et al. Origins, Phytochemistry, Pharmacology, Analytical Methods and Safety of Cortex Moutan (Paeonia suffruticosa Andrew): A Systematic Review[J].Molecules,2017,22(6):946.; Chen Jinpeng, Zhang Kexia, Liu Yi, et al. Research progress on chemical components and pharmacological effects of Rehmannia glutinosa[J].Chinese Herbal Medicine,2021,52(06):1772-1784; Geng Xiaotong. Research progress on chemical components and pharmacological effects of Rehmannia glutinosa[J].Heilongjiang Science,2022,13(24):51-53; Qi Yutong, Zhang Miao, Liu Jianxun, et al. Modern research progress of traditional Chinese medicine Rehmannia glutinosa and prediction analysis of its quality marker (Q-marker)[J].Chinese Journal of Traditional Chinese Medicine,2023,41(12):176-1 84.DOI:10.13193 / j.issn.1673-7717.2023.12.033; Guo Yuting, Zheng Hairong, Zhang Yu, et al. The latest research progress on the chemical components and pharmacological effects of Artemisia annua[J]. Northwest Pharmaceutical Journal, 2023, 38(06):241-249; Mu Huidan, Zhu Jingbo, Ding Yan, et al. UPLC / Q-TOF-MS analysis of chemical components of white peony[J]. Analytical Laboratory, 2013, 32(07):113-117.DOI:10.13595 / j.cnki.issn1000-0720.2013.0196. The obtained compound information was statistically analyzed, and the compound structure was drawn using ChemDraw 20.0 software and saved as a .mol ​​file, or the .mol ​​file was directly downloaded from SciFinder (https: / / scifinder.cas.org) based on the compound information. The statistical data of the chemical component information of each medicinal flavor was imported into UNIFI 1.8 software to obtain the chemical component database of each medicinal flavor of Qingjing Powder.

[0214] Comparison method with the chemical component information database of Qingjingsan:

[0215] In UNIFI 1.8 software, the UNIFI analysis method was established and the chemical component database of each medicinal flavor of Qingjing Powder (the combination of chemical component databases of each medicinal flavor is the chemical component database of the whole prescription) was imported into the analysis method to establish the analysis. The chromatogram information related to the decoction of Qingjing Powder was automatically matched with the compounds in the chemical component information database of the whole prescription, and the compounds with an error within ±5ppm and a response value>10000 were selected. The spectral confirmation with the standard was combined with relevant literature reports, and the fragmentation law analysis was performed to identify the compound structure. The identification results are shown in Table 2.

[0216] Table 2

[0217]

[0218]

[0219]

[0220]

[0221]

[0222]

[0223]

[0224]

[0225]

[0226]

[0227]

[0228]

[0229]

[0230]

[0231]

[0232]

[0233]

[0234]

[0235]

[0236]

[0237]

[0238]

[0239]

[0240]

[0241]

[0242]

[0243]

[0244]

[0245]

[0246]

[0247] Note: ① The “*” in the “Compound” column in the above table indicates that the compound was confirmed after comparison with the standard.

[0248] ②The letters in the “Source” column in the above table represent:

[0249] A: Peony bark; B: White peony root with wine; C: Rehmannia root bark; D: Rehmannia root; E: Phellodendron chinense; F: Artemisia annua; G: Poria.

[0250] ③The letters in the “Classification” column in the above table represent:

[0251] a: carbohydrates; b: phenylpropanoids; c: flavonoids; d: alkaloids; e: terpenes; f: organic acids; g: others.

[0252] 7. Analysis of compound fragmentation rules

[0253] (1) Flavonoids

[0254] A total of 31 flavonoid compounds were characterized, mainly from the medicinal materials Lycium bark, Paeonia suffruticosa, Phellodendron amurense, and Paeonia lactiflora. The cleavage of this type of compound is generally glycosidic bond cleavage, and the cleavage of its flavonoid aglycone is mainly RDA cleavage of the C ring or loss of H 2 O, CO, CO 2 Neutral small molecules. (See: Xu Yanli, Li Chenxi, Yang Feixia, et al. Analysis of chemical components of the classic prescription Shaoyao Gancao Decoction based on UHPLC-Q-Exactive Orbitrap MS technology [J]. Journal of Nanjing University of Traditional Chinese Medicine, 2021, 37(06): 938-948.)

[0255] Taking compound 68 as an example, the retention time is 6.01 min, and in positive ion mode, its quasi-molecular ion peak m / z is 291.1235 [M+H] + , the molecular formula was inferred to be C using Masslynx4.1 workstation (provided by Waters Corporation). 15 H 14 O 6 The secondary mass spectrometry showed that the parent ion lost one molecule of CO to obtain m / z 262.0174, and lost one molecule of C 7 H 6 O 2 The resulting m / z 169.0704 [MC 7 H 6 O 2 ] + , and the fragments are consistent with those of the standard, so it is speculated that this fragmentation pathway is a possible fragmentation pathway for the flavonoid compound catechin.

[0256] (2) Phenylpropanoids

[0257] A total of 39 phenylpropanoid compounds were characterized, mainly from the medicinal materials white peony root, Chinese wolfberry bark, Artemisia annua, and Rehmannia glutinosa. The parent nucleus of this type of compound contains one or several C6-C3 units. According to the structural differences, this type of compound can be divided into three categories: phenylpropanoids, coumarins, and lignins.

[0258] Taking compound 116 as an example, its retention time is 9.98 min. In negative ion mode, its quasi-molecular ion peak is m / z 367.1025 [MH]-. With the help of Masslynx4.1 workstation, the molecular formula is estimated to be C 17 H 20 O 9 , the secondary mass spectrometry showed that the parent ion removed one molecule of H 2 O obtained m / z 349.3140 [MHH 2 O]-, the parent ion loses one molecule of feruloyl to produce a quinic acid molecular ion with m / z 191.0553, and the quinic acid molecular ion further loses H 2 O, producing a fragment ion of m / z 173.0451, which is consistent with the fragment ion reported in the literature (see: Ye Xinyuan, Wu Jianming, Yang Jie, et al. Research progress on the chemical components and mass spectrometry fragmentation characteristics of representative components of Panax notoginseng [J]. Chinese Herbal Medicine, 2021, 52(21): 6687-6700.) and is consistent with the standard fragment ion comparison, so it is speculated that the compound is 3-O-feruloylquinic acid, and its fragmentation pathway is the fragmentation pathway of 3-O-feruloylquinic acid.

[0259] (3) Carbohydrates

[0260] A total of 6 sugar compounds were characterized, mainly from the medicinal material Rehmannia glutinosa. The O-glycosidic bonds of these compounds are easily broken to form monosaccharide fragment ions. In addition, there are also H 2 O, ring opening and other mass spectrometry fragmentation methods.

[0261] Taking compound 9 as an example, the retention time is 0.86 min, and its quasi-molecular ion peak m / z is 689.211 [M+Na] in positive ion mode. + With the help of Masslynx4.1 workstation, the molecular formula was inferred to be C 9 H 10 O 3 , its molecular ion peak m / z is 667.3213[M+H] + The secondary mass spectrometry showed that the parent ion removed one molecule of H 2 O obtained m / z 649.3099 [M+HH 2 O] + , the parent ion removes one molecule of fructose (Fru) to obtain m / z 505.2463 [M+H-Fru] + , and then remove one molecule of glucose (Glu) to obtain m / z 342.2165 [M+H-Fru-Glu] + , and then remove one molecule of glucose (Glu) to obtain m / z 180.1655 [M+H-Fru-Glu-Glu] + ,Based on its fragments, it is speculated that the compound is stachyose, and its cleavage pathway is the stachyose cleavage pathway.

[0262] (4) Organic acids

[0263] A total of 21 organic acid compounds were characterized, mainly derived from the medicinal herb Artemisia annua. This type of compound is prone to produce H 2 O、CO 2 Fragment ions (see: Wang Yingli, Yang Xinxin, Li Tianjiao, et al. Rapid identification of chemical components of modified Bazhen Yimu paste by UPLC-Q-TOF-MS / MS [J]. Central South Pharmacy, 2024, 22(02): 358-367.)

[0264] Taking compound 215 as an example, the retention time is 17.7 min, and its quasi-molecular ion peak m / z is 167.0936 [M+H] in positive ion mode. + With the help of Masslynx4.1 workstation, the molecular formula was inferred to be C 9 H 10 O 3 The secondary mass spectrometry showed that the parent ion had lost one molecule of H 2 O obtained m / z 149.0609 [M+HH 2 O] +The fragments of the pyrolysis fragments were consistent with those of the standard product, so the compound was paeonol. It was speculated that this pyrolysis pathway was a possible pyrolysis pathway for the organic acid compound paeonol.

[0265] (5) Terpenes

[0266] A total of 100 terpenoid compounds were characterized, mainly derived from the medicinal materials Rehmannia glutinosa, white peony root, peony bark, and Artemisia annua. The basic structural unit of this type of compound is isoprene, which is derived from methylvaleric acid. The main cleavage modes in MS include substituent shedding, glycosidic bond cleavage, and hydroxyl shedding. (See: Lu Xingmei, Zhong Lingyun, Wang Shuo, et al. Analysis of the effects of different processing techniques on the chemical composition of Rehmannia glutinosa based on UHPLC-LTQ-Orbitrap MS [J]. Chinese Journal of Traditional Chinese Medicine, 2023, 48(02): 399-414.)

[0267] Taking compound 24 as an example, the retention time is 1.32 min, and in positive ion mode, its quasi-molecular ion peak m / z is 399.1261 [M+Na] + , molecular ion peak m / z is 377.1994[M+H] + The secondary mass spectrometry showed that the parent ion removed one molecule of glucose to obtain m / z 215.1281 [M+H-Glu] + The fragment continues to break the carboxyl group to form CO 2 , its mass spectrum fragment m / z 169.9284[M+H-Glu-CO 2 ] + , continue to break to form H 2 O, its mass spectrum fragment m / z 151.0960 [M+H-Glu-CO 2 -H 2 O] + It is speculated that the compound is 8-epi-strychnine acid, which is consistent with the literature report, and it is speculated that this cleavage mode is the possible cleavage mode of the compound.

[0268] In summary, this example confirms that the chemical components in Qingjing Powder are detected by ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry (UPLC-Q-TOF-MS) coupling technology. By using specific UPLC chromatographic conditions and combining with Q-TOF-MS mass spectrometry conditions, a chromatogram of all components of Qingjing Powder can be quickly obtained. The chromatogram acquisition results are imported into UNIFI 1.8 software to establish an analysis. The chromatogram information related to the Qingjing Powder decoction is quickly obtained and matched with the chemical component information database of the Qingjing Powder whole recipe. The chemical components in Qingjing Powder can be quickly and comprehensively analyzed and characterized, and the detection method has high sensitivity and good separation.

[0269] Comparative Example 1

[0270] The preparation method of the Qingjing Powder medicinal material solution is the same as that of Example 1.

[0271] In the UPLC-Q-TOF-MS detection method, except that the elution gradient is different from that in Example 1, the other conditions and parameters are the same as those in Example 1.

[0272] The elution procedure of this comparative example is shown in Table 3:

[0273] Table 3

[0274]

[0275]

[0276] Fig.17 a in the figure is the UPLC-Q-TOF-MS base peak chromatogram under positive electrode mode of the Qingjingsan whole prescription medicinal material solution obtained by testing using the detection method in Example 1; Fig.17 Middle b is the UPLC-Q-TOF-MS base peak chromatogram under positive electrode mode of the Qingjing San whole prescription medicinal material solution obtained by testing using the detection method in Comparative Example 1.

[0277] Depend on Fig.17 A and Fig.17 By comparison with Example 1, it can be seen that the detection method of Example 1 of the present invention has a shorter detection time, a higher separation degree, and more peaks. According to the identification method in Example 1, it can be seen that the detection method of Example 1 can obtain Fig.17 The compound with a retention time of 12.16 min in a was obtained by using the test method of Comparative Example 1. Fig.17 The retention time in b is 25.43 min, that is, compared with the detection method in Comparative Example 1, the detection method in Example 1 is 13 minutes earlier for the same compound and the number of peaks is not reduced, and more components are characterized after this compound.

[0278] It can be seen from this that the analysis method of the chemical components of Qingjing Powder of the present invention needs to be under a specific mobile phase elution gradient in order to efficiently, quickly, accurately and more comprehensively analyze and characterize the chemical components of Qingjing Powder.

[0279] The above embodiments are only used to illustrate the technical solution of the present application, rather than limiting the same. Those skilled in the art can use the above disclosed technical means and methods to make partial changes to the technical features of the technical solution of the present invention without departing from the scope of the technical solution of the present invention, or modify them into equivalent embodiments with equivalent changes. Therefore, all corresponding technical solutions that do not depart from the technical solution of the present invention are within the protection scope of the present application.

Claims

1. A method for analyzing the chemical components of Qingjing Powder, characterized in that: The steps include: analyzing the Qingjing powder solution by ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry; Wherein, the detection conditions of the ultra-high performance liquid chromatography are: The stationary phase of the chromatographic column is octadecyl bonded silica gel; The mobile phase includes aqueous phase A and organic phase B; The aqueous phase A is a mixture of formic acid and water, wherein the formic acid accounts for 0.1% of the total volume of the aqueous phase A; The organic phase B is acetonitrile; The flow rate of the mobile phase is 0.3 mL / min; The detection condition of the ultra-high performance liquid chromatography is gradient elution, with the total volume of the mobile phase being 100%; within 33 minutes, the volume of the organic phase B increases from 3% to 90%.

2. The method for analyzing the chemical components of Qingjing Powder according to claim 1, characterized in that: The detection conditions of the quadrupole tandem time-of-flight mass spectrometry meet one or more of the following conditions: a. The ion source is an electrospray ionization source (ESI); b. The temperature of the ion source is 100°C; c. The ionization modes are respectively selected as positive ionization mode and negative ionization mode; wherein, in the positive ionization mode, the capillary voltage is 3 kV; and in the negative ionization mode, the capillary voltage is 2 kV; d. Collision energy is 30-60eV; e. The scanning mode is full scan; f. The scanning range is the mass-to-charge ratio (m / z) range of 50-1500Da; g. Scan time is 0.3s; h. The atomizing gas is nitrogen; i. The cone gas is nitrogen; j. The cone sampling voltage is 40V; k. The cone hole gas flow rate is 50L / h; 1. The desolvation temperature is 250°C; m. The desolvation gas flow rate is 600L / h; And / or, the gradient elution of the ultra-high performance liquid chromatography, based on the total volume of the mobile phase as 100%, comprises one or more of the following processes: a. Within 0.5 min, the volume of the organic phase B increased from 3% to 7%; b. Within 3.5 min, the volume of the organic phase B increased from 7% to 13%; c. Within 3 minutes, the volume of the organic phase B increased from 13% to 15%; d. Within 2 minutes, the volume of the organic phase B increased from 15% to 18%; e. Within 3 minutes, the volume of the organic phase B increased from 18% to 25%; f. Within 6 minutes, the volume of the organic phase B increased from 25% to 42%; g. Within 4 minutes, the volume of the organic phase B increased from 42% to 50%; h. Within 2 minutes, the volume of the organic phase B increased from 50% to 59%; i. Within 3 min, the volume of the organic phase B increased from 59% to 67%; j. Within 2 minutes, the volume of the organic phase B increased from 67% to 76%; k. Within 1 min, the volume of the organic phase B increased from 76% to 81%; 1. Within 3 minutes, the volume of the organic phase B increased from 81% to 90%.

3. The method for analyzing the chemical components of Qingjing Powder according to claim 1, characterized in that: The gradient elution of the ultra-high performance liquid chromatography comprises the following process: taking the total volume of the mobile phase as 100%, At 0-2 min, the volume of the organic phase B was 3%; At 2-2.5 min, the volume of the organic phase B was increased from 3% to 7%; At 2.5-6 min, the volume of the organic phase B increased from 7% to 13%; At 6-9 min, the volume of the organic phase B was increased from 13% to 15%; At 9-11 min, the volume of the organic phase B increased from 15% to 18%; At 11-14 min, the volume of the organic phase B increased from 18% to 25%; At 14-20 min, the volume of the organic phase B increased from 25% to 42%; At 20-24 min, the volume of the organic phase B increased from 42% to 50%; At 24-26 min, the volume of the organic phase B increased from 50% to 59%; At 26-29 min, the volume of the organic phase B increased from 59% to 67%; At 29-31 min, the volume of the organic phase B increased from 67% to 76%; At 31-32 min, the volume of the organic phase B increased from 76% to 81%; At 32-35 min, the volume of the organic phase B increased from 81% to 90%; At 35-35.1 min, the volume of the organic phase B decreased from 90% to 3%; At 35.1-37 min, the volume of the organic phase B was 3%.

4. The method for analyzing the chemical components of Qingjing Powder according to claim 1, characterized in that: It meets one or more of the following conditions: (1) The Qingjingsan solution is a Qingjingsan full-formula medicinal material solution, a Qingjingsan single-formula medicinal material solution, or a Qingjingsan missing-formula medicinal material solution; (2) the crude drug concentration of the Qingjingsan solution is 3.6-65.3 mg / mL; (3) The Qingjingsan solution is prepared by the following method, which includes: water decoction and solid phase extraction.

5. The method for analyzing the chemical components of Qingjing Powder according to claim 4, characterized in that: (1) The Qingjing Powder solution is prepared by the following method, which includes: water decoction, volume determination and solid phase extraction; (2) The decoction process comprises: adding 600 mL of water to the Qingjing Powder, soaking for 2 hours, heating the first decoction at a high heat of 500 W until boiling, and keeping the medicinal liquid slightly boiling at a low heat of 200 W, filtering the first decoction while hot through a nylon cloth (300 mesh) after 30 minutes, adding 480 mL of water to the second decoction, heating the second decoction at a high heat of 500 W until boiling, and keeping the medicinal liquid slightly boiling at a low heat of 200 W, filtering the second decoction while hot through a nylon cloth (300 mesh) after 20 minutes, combining the two decoctions, cooling, and measuring the volume to obtain the Qingjing Powder decoction; (3) The solid phase extraction operation includes: accurately measuring 25 mL of the Qingjingsan decoction fixed to 1000 mL into a 50 mL centrifuge tube, centrifuging at a speed of 4000 r / min for 4 minutes, taking the supernatant, saturating a 1g / 6ml 30 / pkg solid phase extraction column with 5 mL of methanol, and then slowly adding 20 mL of the decoction supernatant after centrifugation to the solid phase extraction column. After the loading is completed, 5 mL of pure water is added to remove impurities, and 10 mL of methanol is used for elution. The eluate is transferred to a rotary evaporator and spun dry. The rotary evaporator water bath temperature is 47°C, and 7.5 mL of methanol is accurately transferred to re-dissolve, and filtered through a 0.45 μm nylon membrane.

6. The method for analyzing the chemical components of Qingjing Powder according to claim 1, characterized in that: It meets one or more of the following conditions: (1) The model of the chromatographic column of the ultra-high performance liquid chromatography is Waters ACUITY CSH TM C18 column; (2) The inner diameter of the chromatographic column of the ultra-high performance liquid chromatography is 2.1 mm and the length is 100 mm; (3) In the chromatographic column of the ultra-high performance liquid chromatography, the particle size of the filler is 1.7 μm; (4) The injection volume of the ultra-high performance liquid chromatography is such that the chromatographic peak response value of the ultra-high performance liquid chromatography is e 6 ; (5) The column temperature of the ultra-high performance liquid chromatography is 38-42°C; (6) The temperature of the sample plate of the ultra-high performance liquid chromatography is 8-12°C.

7. The method for analyzing the chemical components of Qingjing Powder according to claim 6, characterized in that: The column temperature of the ultra-high performance liquid chromatography is 40°C; And / or, the temperature of the sample plate of the ultra-high performance liquid chromatography is 10°C.

8. The method for analyzing the chemical components of Qingjing Powder according to claim 1, characterized in that: It meets one or more of the following conditions: (1) The quadrupole tandem time-of-flight mass spectrometer is of Waters XevoG2, manufactured by Waters, USA; (2) the quadrupole tandem time-of-flight mass spectrometer is subjected to internal reference calibration before use; (3) The spectrum of the Qingjing Powder solution obtained by the ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry analysis method is imported into UNIFI 1.8 analysis software to screen and identify the full component compounds of Qingjing Powder, and confirmed in combination with the spectrum of the standard.

9. The method for analyzing the chemical components of Qingjing Powder according to claim 8, characterized in that: It meets one or more of the following conditions: (1) The internal reference calibration is performed using a leucine enkephalin solution, whose theoretical molecular weight is 556.2771 in positive ion mode (ESI+), and whose theoretical molecular weight is 554.2615 in negative ion mode (ESI-); (2) The calibrated flow rate is 5 μL / min; (3) The frequency of the calibration is 5s; (4) The spectrum of the standard product is obtained by detecting the standard product solution by the ultra-high performance liquid chromatography-quadrupole tandem time-of-flight mass spectrometry analysis method; (5) When the molecular weights of the standards are different, a mixed standard solution is injected; when the molecular weights of the standards are the same, the standards are injected individually; (6) The concentration of the standard solution is 0.1-3 mg / mL; (7) The UNIFI 1.8 analysis software includes a chemical composition information library, which is established by collecting literature summaries. The UNIFI 1.8 analysis software is a Waters workstation; (8) When using the UNIFI 1.8 analysis software for identification, compounds with an error within ±5 ppm and a response value >10,000 were selected.

10. The method for analyzing the chemical components of Qingjing Powder according to claim 9, characterized in that: The concentration of the leucine enkephalin solution is 1 μg / L.